Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v3-EN
Language English English
Date Updated 2019-11-01 2019-07-03
Drug Identification Number 02357968 02357968
Brand name TEVA-LOSARTAN TEVA-LOSARTAN
Common or Proper name TEVA-LOSARTAN TEVA-LOSARTAN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LOSARTAN POTASSIUM LOSARTAN POTASSIUM
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-07-02 2019-07-02
Estimated end date 2019-11-30 2019-10-30
Actual end date 2019-10-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments